NBPF11
gene geneOn this page
Summary
NBPF11 (NBPF member 11, HGNC:31993) is a protein-coding gene on chromosome 1q21.2, encoding NBPF family member NBPF11 (Q86T75). It is a selective cancer dependency (DepMap: 60.0% of cell lines).
Predicted to be located in cytoplasm.
Source: NCBI Gene 200030 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 8 total — 1 pathogenic
- Cancer dependency (DepMap): dependent in 60.0% of screened cell lines
- MANE Select transcript:
NM_001385469
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:31993 |
| Approved symbol | NBPF11 |
| Name | NBPF member 11 |
| Location | 1q21.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000263956 |
| Ensembl biotype | protein_coding |
| OMIM | 614001 |
| Entrez | 200030 |
Gene structure
Transcript identifiers
Ensembl transcripts: 23 — 22 protein_coding, 1 nonsense_mediated_decay
ENST00000613531, ENST00000614015, ENST00000614506, ENST00000615281, ENST00000682118, ENST00000906682, ENST00000906683, ENST00000906684, ENST00000917377, ENST00000917378, ENST00000917379, ENST00000917380, ENST00000917381, ENST00000917382, ENST00000917383, ENST00000917384, ENST00000917385, ENST00000917386, ENST00000917387, ENST00000955384, ENST00000955385, ENST00000955386, ENST00000955387
RefSeq mRNA: 15 — MANE Select: NM_001385469
NM_001101663, NM_001385468, NM_001385469, NM_001385470, NM_001385471, NM_001385472, NM_001385473, NM_001385474, NM_001385475, NM_001385476, NM_001385477, NM_001385478, NM_001385479, NM_001385480, NM_183372
CCDS: CCDS41381
Canonical transcript exons
ENST00000682118 — 24 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002700459 | 148143415 | 148143686 |
| ENSE00003458833 | 148106181 | 148106232 |
| ENSE00003495285 | 148135672 | 148135813 |
| ENSE00003509212 | 148106942 | 148107114 |
| ENSE00003558352 | 148107711 | 148107762 |
| ENSE00003613400 | 148137711 | 148137809 |
| ENSE00003713549 | 148118620 | 148118722 |
| ENSE00003715313 | 148122729 | 148122801 |
| ENSE00003715969 | 148116463 | 148116535 |
| ENSE00003717232 | 148122055 | 148122266 |
| ENSE00003724940 | 148115793 | 148115998 |
| ENSE00003727797 | 148105360 | 148105528 |
| ENSE00003736896 | 148110378 | 148110541 |
| ENSE00003739117 | 148123853 | 148124067 |
| ENSE00003740090 | 148102151 | 148103912 |
| ENSE00003742064 | 148114437 | 148114488 |
| ENSE00003742262 | 148126829 | 148127038 |
| ENSE00003745668 | 148108482 | 148108654 |
| ENSE00003746005 | 148120501 | 148120710 |
| ENSE00003751239 | 148104537 | 148104645 |
| ENSE00003751887 | 148109284 | 148109335 |
| ENSE00003753865 | 148117572 | 148117786 |
| ENSE00003754012 | 148124899 | 148125001 |
| ENSE00003920278 | 148151750 | 148152281 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 85.72.
FANTOM5 (CAGE): breadth broad, TPM avg 1.1809 / max 41.6971, expressed in 636 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 201689 | 0.8952 | 469 |
| 201688 | 0.2857 | 133 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| granulocyte | CL:0000094 | 85.72 | gold quality |
| right lobe of liver | UBERON:0001114 | 84.02 | gold quality |
| liver | UBERON:0002107 | 83.95 | gold quality |
| ventricular zone | UBERON:0003053 | 83.82 | gold quality |
| right uterine tube | UBERON:0001302 | 83.12 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.36 | gold quality |
| zone of skin | UBERON:0000014 | 81.21 | gold quality |
| skin of abdomen | UBERON:0001416 | 81.20 | gold quality |
| skin of leg | UBERON:0001511 | 81.11 | gold quality |
| endocervix | UBERON:0000458 | 80.93 | gold quality |
| body of pancreas | UBERON:0001150 | 80.90 | gold quality |
| sural nerve | UBERON:0015488 | 80.86 | gold quality |
| spleen | UBERON:0002106 | 80.72 | gold quality |
| ovary | UBERON:0000992 | 80.64 | gold quality |
| tonsil | UBERON:0002372 | 80.62 | gold quality |
| body of stomach | UBERON:0001161 | 80.48 | gold quality |
| left ovary | UBERON:0002119 | 80.48 | gold quality |
| body of uterus | UBERON:0009853 | 80.36 | gold quality |
| right ovary | UBERON:0002118 | 80.29 | gold quality |
| stromal cell of endometrium | CL:0002255 | 80.22 | gold quality |
| uterine cervix | UBERON:0000002 | 80.00 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 79.98 | gold quality |
| apex of heart | UBERON:0002098 | 79.95 | gold quality |
| mucosa of stomach | UBERON:0001199 | 79.81 | gold quality |
| cortex of kidney | UBERON:0001225 | 79.76 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 79.74 | gold quality |
| myometrium | UBERON:0001296 | 79.58 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 79.44 | gold quality |
| stomach | UBERON:0000945 | 79.40 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 79.40 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.59 |
| E-MTAB-7606 | no | 234.96 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
77 targeting NBPF11, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-4692 | 100.00 | 67.32 | 2066 |
| HSA-MIR-4534 | 99.99 | 66.58 | 1907 |
| HSA-MIR-3065-5P | 99.97 | 71.56 | 3281 |
| HSA-MIR-3605-5P | 99.96 | 67.12 | 932 |
| HSA-MIR-8082 | 99.95 | 67.27 | 1170 |
| HSA-MIR-3912-5P | 99.95 | 66.11 | 925 |
| HSA-MIR-141-3P | 99.94 | 72.79 | 2421 |
| HSA-MIR-200A-3P | 99.94 | 72.68 | 2420 |
| HSA-MIR-3529-3P | 99.90 | 73.55 | 3045 |
| HSA-MIR-3671 | 99.90 | 73.04 | 3897 |
| HSA-MIR-124-3P | 99.89 | 73.74 | 3043 |
| HSA-MIR-506-3P | 99.89 | 73.55 | 3057 |
| HSA-MIR-10395-5P | 99.86 | 67.35 | 676 |
| HSA-MIR-544A | 99.84 | 68.66 | 1965 |
| HSA-MIR-4659A-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4659B-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4319 | 99.76 | 69.83 | 2586 |
| HSA-MIR-4255 | 99.72 | 67.70 | 1541 |
| HSA-MIR-33A-3P | 99.70 | 70.27 | 3362 |
| HSA-MIR-545-5P | 99.66 | 70.18 | 2308 |
| HSA-MIR-10394-5P | 99.65 | 66.83 | 1852 |
| HSA-MIR-1205 | 99.65 | 66.76 | 1826 |
| HSA-MIR-548AV-5P | 99.60 | 70.84 | 2107 |
| HSA-MIR-548K | 99.60 | 70.84 | 2107 |
| HSA-MIR-4762-5P | 99.57 | 68.54 | 1424 |
| HSA-MIR-549A-3P | 99.54 | 68.17 | 825 |
| HSA-MIR-7106-5P | 99.53 | 67.47 | 3574 |
| HSA-MIR-1207-5P | 99.49 | 69.11 | 2983 |
| HSA-MIR-8054 | 99.48 | 70.81 | 2084 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 60.0% of screened cell lines.
Cross-species orthologs
0 orthologs
Paralogs (14): NBPF3 (ENSG00000142794), NBPF20 (ENSG00000162825), NBPF6 (ENSG00000186086), NBPF4 (ENSG00000196427), NBPF1 (ENSG00000219481), NBPF15 (ENSG00000266338), NBPF12 (ENSG00000268043), NBPF9 (ENSG00000269713), NBPF8 (ENSG00000270231), NBPF14 (ENSG00000270629), (ENSG00000271254), NBPF19 (ENSG00000271383), NBPF10 (ENSG00000271425), NBPF26 (ENSG00000273136)
Protein
Protein identifiers
NBPF family member NBPF11 — Q86T75 (reviewed: Q86T75)
Alternative names: Neuroblastoma breakpoint family member 11, Neuroblastoma breakpoint family member 24
All UniProt accessions (3): Q86T75, A0A087WTH4, A0A087WUF5
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Cytoplasm.
Tissue specificity. Expressed in spinal cord.
Miscellaneous. Encoded by one of the numerous copies of NBPF genes clustered in the p36, p12 and q21 region of the chromosome 1.
Similarity. Belongs to the NBPF family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q86T75-1 | 1 | yes |
| Q86T75-2 | 2 |
RefSeq proteins (15): NP_001095133, NP_001372397, NP_001372398, NP_001372399, NP_001372400, NP_001372401, NP_001372402, NP_001372403, NP_001372404, NP_001372405, NP_001372406, NP_001372407, NP_001372408, NP_001372409, NP_899228 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR010630 | Olduvai_dom | Domain |
| IPR055306 | NBPF | Family |
Pfam: PF06758
UniProt features (20 total): domain 6, compositionally biased region 5, region of interest 4, coiled-coil region 2, splice variant 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q86T75-F1 | 49.78 | 0.05 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 49 (showing top):
BENPORATH_ES_WITH_H3K27ME3, WWTAAGGC_UNKNOWN, AACTTT_UNKNOWN, OSMAN_BLADDER_CANCER_DN, ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN, chr1q21, CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP, LU_EZH2_TARGETS_DN, RATTENBACHER_BOUND_BY_CELF1, HMG20B_TARGET_GENES, PTTG1_TARGET_GENES, UBN1_TARGET_GENES, ZFP91_TARGET_GENES, ZNF213_TARGET_GENES, ZNF592_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
446 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NBPF11 | ACP6 | Q9NPH0 | 696 |
| NBPF11 | FMO5 | P49326 | 654 |
| NBPF11 | CHD1L | Q86WJ1 | 581 |
| NBPF11 | PRKAB2 | O43741 | 575 |
| NBPF11 | GJA8 | P48165 | 574 |
| NBPF11 | NOTCH2NLB | P0DPK3 | 571 |
| NBPF11 | BCL9 | O00512 | 517 |
| NBPF11 | GPHRA | B7ZAQ6 | 507 |
| NBPF11 | PPIAL4D | F5H284 | 478 |
| NBPF11 | HYDIN | Q4G0P3 | 474 |
| NBPF11 | NUDT17 | P0C025 | 447 |
| NBPF11 | SPDYE5 | A6NIY4 | 446 |
| NBPF11 | GJA5 | P36382 | 446 |
| NBPF11 | LIX1L | Q8IVB5 | 445 |
| NBPF11 | POLR3GL | Q9BT43 | 435 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| BKRF1 | NBPF11 | psi-mi:“MI:0915”(physical association) | 0.370 |
| NEK4 | E2F8 | psi-mi:“MI:0914”(association) | 0.350 |
| RPL27A | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (9): NBPF11 (Affinity Capture-MS), NBPF11 (Negative Genetic), NBPF11 (Affinity Capture-RNA), CBY1 (Two-hybrid), CBY1 (Affinity Capture-Western), NBPF11 (Affinity Capture-Western), NBPF11 (Two-hybrid), NBPF11 (Reconstituted Complex), NBPF11 (Reconstituted Complex)
ESM2 similar proteins: A0A087WUL8, A0A0J9YWL9, A0A0U1RQI7, A0A1D9BZF0, A6NJU9, A6NKU9, A6NNC1, A6QL64, A8MRT5, B2SU53, B4DH59, B5DUH6, C9JG80, E5RHQ5, F8W0I5, P01068, P02895, P06916, P07907, P0DKL2, P0DPF3, P0DRJ4, P13208, P14417, P32072, P83060, Q26755, Q3BBV0, Q3BBV2, Q4ZJY7, Q4ZJZ0, Q4ZJZ1, Q4ZJZ3, Q5TAG4, Q5TI25, Q6P3W6, Q6RY98, Q7T3L1, Q86SG3, Q86T75
Diamond homologs: A0A087WUL8, B4DH59, P0C2Y1, P0DPF2, P0DPF3, Q32LC2, Q3BBV0, Q3BBV2, Q5TAG4, Q5TI25, Q5VU43, Q5VWK0, Q6P3W6, Q86T75, Q86XG9, Q8N660, Q96M43, Q9H094, A0A096LNW5, A2RUV0, G3I6Z6, O35516, P0DPK3, P0DPK4, P10040, P21783, P46530, P46531, Q01705, Q04721, Q04756, Q07008, Q20911, Q7Z3S9, Q80YT7, Q99466, Q9QW30, Q9UM47, Q19UN5, Q8K389
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
8 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 6 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 565170 | GRCh37/hg19 1q21.1-21.2(chr1:145895746-147926347)x1 | Pathogenic |
SpliceAI
594 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:148106177:T:A | donor_loss | 1.0000 |
| 1:148106178:GTAA:G | donor_loss | 1.0000 |
| 1:148106179:GGT:G | donor_loss | 1.0000 |
| 1:148106180:AG:A | donor_loss | 1.0000 |
| 1:148106181:CAG:C | donor_loss | 1.0000 |
| 1:148106182:CCAG:C | donor_loss | 1.0000 |
| 1:148106939:G:GG | donor_gain | 1.0000 |
| 1:148106943:GACA:G | donor_gain | 1.0000 |
| 1:148126826:G:GG | donor_gain | 1.0000 |
| 1:148106231:GG:G | acceptor_gain | 0.9900 |
| 1:148106231:GGA:G | acceptor_gain | 0.9900 |
| 1:148106232:A:G | acceptor_loss | 0.9900 |
| 1:148106232:AG:A | acceptor_gain | 0.9900 |
| 1:148106235:TGCA:T | acceptor_loss | 0.9900 |
| 1:148106935:G:C | donor_loss | 0.9900 |
| 1:148106936:AG:A | donor_loss | 0.9900 |
| 1:148106937:G:GT | donor_loss | 0.9900 |
| 1:148106938:TGAGT:T | donor_loss | 0.9900 |
| 1:148106939:GT:G | donor_loss | 0.9900 |
| 1:148106940:AG:A | donor_loss | 0.9900 |
| 1:148106941:CA:C | donor_gain | 0.9900 |
| 1:148106941:CAG:C | donor_loss | 0.9900 |
| 1:148106943:GACAG:G | donor_gain | 0.9900 |
| 1:148106944:GGACA:G | donor_gain | 0.9900 |
| 1:148107113:G:A | acceptor_loss | 0.9900 |
| 1:148107113:G:GA | acceptor_gain | 0.9900 |
| 1:148107113:GG:G | acceptor_gain | 0.9900 |
| 1:148107114:A:AG | acceptor_gain | 0.9900 |
| 1:148107114:AG:A | acceptor_gain | 0.9900 |
| 1:148107114:AGG:A | acceptor_loss | 0.9900 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1043522 (1:148103375 T>A,C), RS1043820 (1:148102423 T>C), RS1043825 (1:148102414 G>A), RS1043841 (1:148102384 T>C), RS1043856 (1:148102335 G>C,T), RS1043877 (1:148102275 A>C), RS1061849 (1:148133414 T>C), RS1065169 (1:148102397 G>A), RS1065171 (1:148102394 C>T), RS1065172 (1:148102389 A>C), RS1065200 (1:148102285 C>A,G,T), RS1065203 (1:148102282 A>G), RS10900300 (1:148113082 A>T), RS111239941 (1:148119556 G>A,T), RS111373154 (1:148123027 A>G)
Disease associations
OMIM: gene MIM:614001 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Air Pollutants | affects expression, increases abundance, increases expression | 3 |
| Particulate Matter | increases abundance, increases expression, decreases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | affects cotreatment, decreases expression | 1 |
| 2-butenal | decreases expression | 1 |
| manganese chloride | decreases expression, increases abundance | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Coumestrol | increases expression | 1 |
| Dexamethasone | affects cotreatment, decreases expression | 1 |
| Indomethacin | affects cotreatment, decreases expression | 1 |
| Manganese | decreases expression, increases abundance | 1 |
| Ozone | increases abundance, affects expression | 1 |
| Pesticides | decreases expression | 1 |
| Smoke | increases abundance, increases expression | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, decreases expression | 1 |
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.